Cantabio Pharmaceuticals Inc. (CTBO: OTCQB) | Cantabio Pharmaceuticals to Present Positive in vivo Efficacy Data in a Mice Model of Parkinson’s disease from Its DJ-1 Protein Targeting Therapeutic Program at the Neuro4D Conference in Mainz, Germany
(0)
(0)